Results 131 to 140 of about 8,086 (190)

The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour’s TMPRSS2-ERG Fusion Status

Prostate Cancer, 2019
Objectives. To investigate the added value of assessing transcripts for the long cAMP phosphodiesterase-4D (PDE4D) isoforms, PDE4D5 and PDE4D9, regarding the prognostic power of the ‘CAPRA & PDE4D7’ combination risk model to predict longitudinal ...
Dianne van Strijp, Christiane de Witz, Birthe Heitkötter, Sebastian Huss, Martin Bögemann, George S. Baillie, Miles D. Houslay, Chris Bangma, Axel Semjonow, Ralf Hoffmann   +9 more
doaj   +1 more source

Profile of chimeric RNAs and TMPRSS2-ERG e2e4 isoform in neuroendocrine prostate cancer. [PDF]

Cell Biosci, 2022
Wang Q, Chen J, Singh S, Xie Z, Qin F, Shi X, Cornelison R, Li H, Huang H.   +8 more
europepmc   +1 more source

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. [PDF]

Cancers (Basel), 2023
von Danwitz M, Klümper N, Bernhardt M, Cox A, Krausewitz P, Alajati A, Kristiansen G, Ritter M, Ellinger J, Stein J.   +9 more
europepmc   +1 more source

TMPRSS2/ERG Fusions [PDF]

, 2008
Jianghua Wang, Yi Cai, Michael Ittmann
openaire   +1 more source

TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence. [PDF]

Cancer Gene Ther, 2022
Fang L, Li D, Yin J, Pan H, Ye H, Bowman J, Capaldo B, Kelly K.   +7 more
europepmc   +1 more source

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer. [PDF]

Front Oncol, 2022
Lazzeri M, Fasulo V, Lughezzani G, Benetti A, Soldà G, Asselta R, De Simone I, Paciotti M, Avolio PP, Contieri R, Saitta C, Saita A, Hurle R, Guazzoni G, Buffi NM, Casale P.   +15 more
europepmc   +1 more source

INTEGRATIVE ANALYSIS OF OMICS DATA IN ADULT GLIOMA AND OTHER TCGA CANCERS TO GUIDE PRECISION MEDICINE [PDF]

, 2017
Transcriptomic profiling and gene expression signatures have been widely applied as effective approaches for enhancing the molecular classification, diagnosis, prognosis or prediction of therapeutic response towards personalized therapy for cancer ...
hu, Xin, hu, xin
core   +1 more source

The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer

BMC Cancer
Background This review offers a distinctive perspective by integrating and critically evaluating the latest advancements in non-invasive biomarkers for Prostate-Specific Antigen (PSA) gray-zone prostate cancer.
Yeasin Ahamed, Marofe Hossain, Shantanu Baral, Ashab Uddin Al-Raiyan, Sabiba Bintay Ashraf, Weigui Sun   +5 more
doaj   +1 more source

ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate Cancer. [PDF]

Int J Mol Sci, 2022
Kobelyatskaya AA, Kudryavtsev AA, Kudryavtseva AV, Snezhkina AV, Fedorova MS, Kalinin DV, Pavlov VS, Guvatova ZG, Naberezhnev PA, Nyushko KM, Alekseev BY, Krasnov GS, Bulavkina EV, Pudova EA.   +13 more
europepmc   +1 more source

TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target

Medeniyet Medical Journal
The transmembrane serine protease 2 (TMPRSS2) gene plays a crucial role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by priming the viral spike protein for membrane fusion and facilitating viral entry into host cells.
Haily Liduin KOYOU, Mohd Nazil SALLEH, Caroline Satu JELEMIE, Mohd Jaamia Qaadir BADRIN, Muhammad Evy PRASTIYANTO, Vasudevan RAMACHANDRAN   +5 more
doaj   +1 more source